EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma

Xiyu Song, Yumeng Zhu, Wenwen Geng, Jianhua Jiao, Hongjiao Liu, Ruo Chen, Qian He, Lijuan Wang, Xiuxuan Sun, Weijun Qin, Jiejie Geng, Zhinan Chen

Journal for ImmunoTherapy of Cancer · 2025-01 · 13 (1) · e010183

DOI: 10.1136/jitc-2024-010183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 04.01.2025. Verfasst von Xiyu Song und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, T-Lymphocytes, Regulatory, Kidney Neoplasms, Transcriptome. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: State Key Laboratory, Natural Science Basic Research Program of Shaanxi Province, Innovation Capability Support Program of Shaanxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clear cell renal cell carcinoma (ccRCC) is the most common histologic type of RCC. However, the spatial and functional heterogeneity of immunosuppressive cells and the mechanisms by which their interactions promote immunosuppression in the ccRCC have not been thoroughly investigated.

Methods

To further investigate the cellular and regional heterogeneity of ccRCC, we analyzed single-cell and spatial transcriptome RNA sequencing data from four patients, which were obtained from samples from multiple regions, including the tumor core, tumor-normal interface, and distal normal tissue. On the basis, the findings were investigated in vitro using tissue and blood samples from 15 patients with ccRCC and validated in the broader samples on tissue microarrays.

Results

In this study, we revealed previously unreported subsets of both stromal and immune cells, as well as mapped their spatial location at finer resolution. In addition, we validated the clusters of tumor cells after removing batch effects according to six characterized gene sets, including epithelial-mesenchymal transition high clusters, metastatic clusters and proximal tubule high clusters. Importantly, we identified a special regulatory T (Treg) cell subpopulation that has the molecular characteristics of terminal effector Treg cells but expresses multiple cytokines, such as interleukin (IL)-1β and IL-18. This group of Treg cells has stronger immunosuppressive function and was associated with a worse prognosis in ccRCC cohorts. They were colocalized with MRC1 + FOLR2 + tumor-associated macrophages (TAMs) at the tumor-normal interface to form a positive feedback loop, maintaining a synergistic procarcinogenic effect. In addition, we traced the origin of IL-1β + Treg cells and revealed that IL-18 can induce the expression of IL-1β in Treg cells via the ERK/NF-κB pathway.

Conclusions

We demonstrated a novel cancer-promoting Treg cell subset and its interactions with MRC1 + FOLR2 + TAMs, which provides new insight into Treg cell heterogeneity and potential therapeutic targets for ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellT-Lymphocytes, RegulatoryKidney NeoplasmsTranscriptomeHumansSingle-Cell AnalysisTumor MicroenvironmentMaleFemale

Stichwörter der Autor:innen

ImmunosuppressionImmunotherapyKidney CancerT regulatory cell - TregTumor Microenvironment

Autor:innen und Institutionen

  • National Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, China.
  • Xijing Innovation Research Institute, Fourth Military Medical University, Xi'an, Shaanxi, China.
  • Department of Breast Surgery, Shandong University, Jinan, Shandong, China.
  • Department of Urology, Fourth Military Medical University, Xi'an, Shaanxi, China.
  • Department of Urology, Fourth Military Medical University, Xi'an, Shaanxi, China qinwj@fmmu.edu.cn gengjie-jie@163.com znchen@fmmu.edu.cn.
  • National Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, China qinwj@fmmu.edu.cn gengjie-jie@163.com znchen@fmmu.edu.cn.

Förderung

  • State Key Laboratory
  • Natural Science Basic Research Program of Shaanxi Province
  • Innovation Capability Support Program of Shaanxi
  • National Natural Science Foundation of China
  • Xijing Hospital

Zitieren

APA

Song, X., Zhu, Y., Geng, W., Jiao, J., Liu, H., Chen, R., He, Q., Wang, L., Sun, X., Qin, W., Geng, J., & Chen, Z. (2025). Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma. Journal for ImmunoTherapy of Cancer, 13(1), e010183. https://doi.org/10.1136/jitc-2024-010183

Vancouver

Song X, Zhu Y, Geng W, Jiao J, Liu H, Chen R, et al. Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 2025;13(1):e010183. doi:10.1136/jitc-2024-010183

BibTeX
@article{Song2025,
  author = {Song, Xiyu and Zhu, Yumeng and Geng, Wenwen and Jiao, Jianhua and Liu, Hongjiao and Chen, Ruo and He, Qian and Wang, Lijuan and Sun, Xiuxuan and Qin, Weijun and Geng, Jiejie and Chen, Zhinan},
  title = {Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  volume = {13},
  number = {1},
  pages = {e010183},
  doi = {10.1136/jitc-2024-010183}
}
Kostenlos starten →